StockTipsArenaBeta

BUY Alembic Pharmaceuticals Limited — Manas Jaiswal

BUYAlembic Pharmaceuticals Limited
Alembic Pharmaceuticals share price target & all analyst calls

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))8 May 2026via CNBC Awaaz.

Entry₹794.75Inferred
Target₹840
Total upside +5.69% (call closed)
Stop loss₹774-2.61% risk
Exit₹77411 May 2026, 9:15 am
Stop-loss hit-2.61%
Follow Manas Jaiswal for new calls(30% target hit, 374 closed calls)Get alertsWatch APLLTD for new buy/sell callsGet alertsSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:48 am IST
1 supporting0 opposing
Supports the BUY call (1)

Alembic Pharmaceuticals Ltd has received final approval from the USFDA for its Fingolimod Capsules, 0.5 mg.

BSE · Company Update·25 Apr · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Alembic Pharmaceuticals

All analyst calls on Alembic Pharmaceuticals

More from Manas Jaiswal

Every call and its outcome